Neuren Pharmaceuticals | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Alaunos Therapeutics USD 2.06M 661K 2024-12
Avita Medical AUD 4.5M 19.42M 2024-12
Clinuvel Pharmaceuticals AUD 203.01M 24.36M 2024-06
Dianthus Therapeutics USD 352.48M 14.58M 2024-12
Ecofibre AUD 40.97M 10.34M 2024-06
Genetic Signatures AUD 61.1M 20.6M 2024-06
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
Medical Developments International AUD 45.73M 29.96M 2024-06
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Organon & Co USD 472M 21M 2024-12
Paradigm Biopharmaceuticals AUD 23.81M 9.99M 2024-06
PYC Therapeutics AUD 81.05M 51.15M 2024-06
Starpharma Holdings AUD 28.12M 6.34M 2024-06
Tectonic Therapeutic USD 140.78M 9.58M 2024-12
Telix Pharmaceuticals AUD 568.21M 164.24M 2024-12
Viatris USD 18.64B 1.16B 2024-12
Xeris Pharmaceuticals USD -29615000 1.29M 2024-12



Neuren Pharmaceuticals Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.